Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuzo Urata

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Antiviral Research|March 1, 2022
Identification of novel chemical compounds targeting filovirus VP40-mediated particle productionShuzo Urata, Olaposi Idowu Omotuyi, Ayako Izumisawa, et al.
Scientific Reports|August 27, 2017
Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interactionKen Watanabe, Takeshi Ishikawa, Hiroki Otaki, et al.
Journal of Medical Microbiology|March 6, 2026
Molecular epidemiology of rodent-borne <i>Leptospira</i> spp. in Sri Lanka: identification of novel sequence types and previously unrecognized reservoir animalsNipun Rathnayake, Kyosuke Takabe, Devinda Muthusinghe, et al.
Tropical Medicine and Health|February 24, 2026
Serological profiling of hantavirus infections in chronic kidney disease of unknown etiology non-endemic regions of Sri LankaPavani Senarathne, Nipun Rathnayake, Rydhnieya Vijeyakumaran, et al.
Cell Host & Microbe|March 16, 2011
Hypomorphic mutation in the site-1 protease Mbtps1 endows resistance to persistent viral infection in a cell-specific mannerDaniel L Popkin, John R Teijaro, Brian M Sullivan, et al.
Biochemical and Biophysical Research Communications|August 31, 2023
Characterization of novel, severely immunodeficient Prkdc<sup>Δex57/Δex57</sup> miceYumie Takagi, Katsuko Sudo, Sachiko Yamaguchi, et al.
Antiviral Research|February 5, 2022
Corrigendum to "The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection" [Antivir. Res. vol 192 (2021) 1-13/105121]Sandra Kendra Raini, Yuki Takamatsu, Shyam Prakash Dumre, et al.
Antiviral Research|June 27, 2021
The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infectionSandra Kendra Raini, Yuki Takamatsu, Shyam Prakash Dumre, et al.
Viruses|September 28, 2021
CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry InhibitorToru Takenaga, Zihan Zhang, Yukiko Muramoto, et al.
Journal of Virology|May 29, 2024
Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entryZihan Zhang, Toru Takenaga, Sarah Katharina Fehling, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Antiviral Research|March 1, 2022
Identification of novel chemical compounds targeting filovirus VP40-mediated particle productionShuzo Urata, Olaposi Idowu Omotuyi, Ayako Izumisawa, et al.
Scientific Reports|August 27, 2017
Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interactionKen Watanabe, Takeshi Ishikawa, Hiroki Otaki, et al.
Journal of Medical Microbiology|March 6, 2026
Molecular epidemiology of rodent-borne <i>Leptospira</i> spp. in Sri Lanka: identification of novel sequence types and previously unrecognized reservoir animalsNipun Rathnayake, Kyosuke Takabe, Devinda Muthusinghe, et al.
Tropical Medicine and Health|February 24, 2026
Serological profiling of hantavirus infections in chronic kidney disease of unknown etiology non-endemic regions of Sri LankaPavani Senarathne, Nipun Rathnayake, Rydhnieya Vijeyakumaran, et al.
Cell Host & Microbe|March 16, 2011
Hypomorphic mutation in the site-1 protease Mbtps1 endows resistance to persistent viral infection in a cell-specific mannerDaniel L Popkin, John R Teijaro, Brian M Sullivan, et al.
Biochemical and Biophysical Research Communications|August 31, 2023
Characterization of novel, severely immunodeficient Prkdc<sup>Δex57/Δex57</sup> miceYumie Takagi, Katsuko Sudo, Sachiko Yamaguchi, et al.
Antiviral Research|February 5, 2022
Corrigendum to "The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection" [Antivir. Res. vol 192 (2021) 1-13/105121]Sandra Kendra Raini, Yuki Takamatsu, Shyam Prakash Dumre, et al.
Antiviral Research|June 27, 2021
The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infectionSandra Kendra Raini, Yuki Takamatsu, Shyam Prakash Dumre, et al.
Viruses|September 28, 2021
CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry InhibitorToru Takenaga, Zihan Zhang, Yukiko Muramoto, et al.
Journal of Virology|May 29, 2024
Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entryZihan Zhang, Toru Takenaga, Sarah Katharina Fehling, et al.
Pageof 6